lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride

C43H35Br2ClF2LiN15O5 — CID 160857623

About lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride

lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride (PubChem CID 160857623) has the molecular formula C43H35Br2ClF2LiN15O5 and a molecular weight of 1082.05 g/mol. Its IUPAC name is lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride.

Molecular Properties

• Compound Name: lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride
• PubChem CID: 160857623
• Molecular Formula: C43H35Br2ClF2LiN15O5
• Molecular Weight: 1082.05 g/mol
• Exact Mass: 1079.11
• IUPAC Name: lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride
• SMILES: Cl.NCc1ncn2ccc(Br)c(F)c12.O=C(CCc1ncn2ccc(Br)c(F)c12)c1nnc(Cc2cn3nc(C4CC4)ccc3n2)o1.O=C([O-])c1nnc(Cc2cn3nc(C4CC4)ccc3n2)o1.[Li+]
• InChI: InChI=1S/C22H17BrFN7O2.C13H11N5O3.C8H7BrFN3.ClH.Li/c23-14-7-8-30-11-25-16(21(30)20(14)24)3-5-17(32)22-28-27-19(33-22)9-13-10-31-18(26-13)6-4-15(29-31)12-1-2-12;19-13(20)12-16-15-11(21-12)5-8-6-18-10(14-8)4-3-9(17-18)7-1-2-7;9-5-1-2-13-4-12-6(3-11)8(13)7(5)10;;/h4,6-8,10-12H,1-3,5,9H2;3-4,6-7H,1-2,5H2,(H,19,20);1-2,4H,3,11H2;1H;/q;;;;+1/p-1
• InChIKey: XHVJOZCNINIEIQ-UHFFFAOYSA-M
• XLogP: 3.01
• TPSA: 256.04 Ų
• H-Bond Donors: 1
• H-Bond Acceptors: 20
• Rotatable Bonds: 12
• Heavy Atoms: 69
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	1082.05
LogP ≤ 5	3.01
H-Bond Donors ≤ 5	1
H-Bond Acceptors ≤ 10	20

Frequently Asked Questions

What is the IUPAC name of lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride?

The IUPAC name of lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride (CID 160857623) is lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride.

What is the SMILES notation for lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride?

The canonical SMILES for lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride is Cl.NCc1ncn2ccc(Br)c(F)c12.O=C(CCc1ncn2ccc(Br)c(F)c12)c1nnc(Cc2cn3nc(C4CC4)ccc3n2)o1.O=C([O-])c1nnc(Cc2cn3nc(C4CC4)ccc3n2)o1.[Li+].

What is the InChIKey of lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride?

The InChIKey is XHVJOZCNINIEIQ-UHFFFAOYSA-M. The full InChI is InChI=1S/C22H17BrFN7O2.C13H11N5O3.C8H7BrFN3.ClH.Li/c23-14-7-8-30-11-25-16(21(30)20(14)24)3-5-17(32)22-28-27-19(33-22)9-13-10-31-18(26-13)6-4-15(29-31)12-1-2-12;19-13(20)12-16-15-11(21-12)5-8-6-18-10(14-8)4-3-9(17-18)7-1-2-7;9-5-1-2-13-4-12-6(3-11)8(13)7(5)10;;/h4,6-8,10-12H,1-3,5,9H2;3-4,6-7H,1-2,5H2,(H,19,20);1-2,4H,3,11H2;1H;/q;;;;+1/p-1.

What are the key properties of lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride?

lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride has a molecular weight of 1082.05 g/mol, XLogP of 3.01, 12 rotatable bonds, 1 hydrogen bond donors, and 20 hydrogen bond acceptors.

Where does this data come from?

All data for lithium;3-(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)-1-[5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one;(7-bromo-8-fluoroimidazo[1,5-a]pyridin-1-yl)methanamine;5-[(6-cyclopropylimidazo[1,2-b]pyridazin-2-yl)methyl]-1,3,4-oxadiazole-2-carboxylate;hydrochloride is sourced from PubChem (CID 160857623), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).